| Feature |
N of patients |
| Sex |
| Male |
38 |
| Female |
35 |
| Agegroup (years) |
| 20-30 |
5 |
| 31-40 |
2 |
| 41-50 |
7 |
| 51-60 |
22 |
| 61-70 |
19 |
| >70 |
18 |
| LymphomaStage |
| I |
18 |
| II |
26 |
| III |
15 |
| IV |
14 |
| LymphadenopathyTopography |
| Cervical |
28 |
| Mediastinum |
1 |
| Axillary |
5 |
| Inguinal |
9 |
| Retroperitoneal |
3 |
| Multiple |
23 |
| B Symptoms |
| Absent |
50 |
| Present |
23 |
| International Prognosis Index |
| 1 |
34 |
| 2 |
19 |
| 3 |
14 |
| 4 |
6 |
| |
Median (range) |
| Follow-up period |
39 (6-190) months |
| Events during the follow-up |
| RelapsedPatients |
35 |
| Dead Patients |
45 |
|
| Note: When columns do not sum to the total, data were missing or unknown. |
| Table 1: Some of the main clinical and pathological features of the studied population are summarized in this table. The median length of the follow-up period and the patient outcome are shown. |
